Showing results (21-30 of 71) with videos related to
Sort By:
Pageof 8
Journal of Pediatric Orthopedics. Part B|April 13, 2004
Langerhans cell histiocytosis of the cervical spine: a single institution experience in four patientsGrace Tan, Ignace Samson, Ivo De Wever, et al.Genes and Immunity|February 17, 2022
Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patientsStefaan W Van Gool, Jennifer Makalowski, Michael Bitar, et al.Scientific Reports|October 26, 2017
Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survivalJochen Belmans, Matthias Van Woensel, Brecht Creyns, et al.Cancers|December 30, 2020
Randomized Controlled Immunotherapy Clinical Trials for GBM ChallengedStefaan W Van Gool, Jennifer Makalowski, Simon Fiore, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 8, 2011
Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcomaAn Coosemans, Ben Van Calster, Godelieve Verbist, et al.Cell Transplantation|April 9, 2013
Mutual interaction between human multipotent adult progenitor cells and NK cellsSandra A Jacobs, Jeroen Plessers, Jef Pinxteren, et al.Science Translational Medicine|March 4, 2016
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade gliomaAbhishek D Garg, Lien Vandenberk, Carolien Koks, et al.Cancer Immunology, Immunotherapy : CII|February 5, 2005
Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cellsSteven De Vleeschouwer, Mohammed Arredouani, Martine Adé, et al.Gynecologic Oncology|October 22, 2008
Wilms' tumor gene 1 (WT1) in endometrial carcinomaAn Coosemans, Philippe Moerman, Godelieve Verbist, et al.Anticancer Research|October 15, 2010
Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinomaAnn Coosemans, Matthias Wölfl, Zwi N Berneman, et al.Pageof 8